Capillary Blood Glucose Monitoring Frequency
Insulin-Treated Patients
- The American Diabetes Association recommends CBG testing at least 4 times daily for patients on multiple daily insulin injections or insulin pump therapy, with testing before each meal and snack, at bedtime, prior to exercise, and when hypoglycemia is suspected 1, 2, 4
- Testing 4 or more times per day is associated with significantly better HbA1c control compared to less frequent monitoring, with a reduction in HbA1c levels 1, 2, 3
- The American Diabetes Association also recommends testing after treating hypoglycemia until normoglycemia is confirmed, and before and during critical tasks such as driving 4
Type 2 Diabetes Patients
- For insulin-treated type 2 diabetes patients, the recommended frequency is similar to type 1 diabetes, at least 4 times daily for those on intensive insulin regimens 1, 2
- Routine CBG monitoring is not recommended for patients managed with diet and/or oral agents alone, as more frequent testing in this population is paradoxically associated with higher HbA1c levels 6
Hospitalized Patients
- In the non-critical care setting, CBG testing is recommended before each meal for patients who are eating, and every 4-6 hours for patients not eating or with restricted oral intake 7, 8
- In the critical care setting, CBG testing is recommended every 30 minutes to 2 hours when using intravenous insulin infusion, with more frequent monitoring required for IV insulin administration 7, 8
Special Populations
- For gestational diabetes, fasting and postprandial monitoring is recommended, with target values of fasting <5.3 mmol/L and either 1-hour postprandial <7.8 mmol/L or 2-hour postprandial <6.7 mmol/L 6
- For pancreatogenic diabetes, CBG testing is recommended before meals, at bedtime, and when hypoglycemia is suspected for patients on intensive insulin regimens, with regular monitoring crucial given the high risk of hypoglycemia in this population 5
Important Caveats
- Real-time CGM can replace most CBG testing in appropriate patients, though some systems still require periodic CBG for calibration, and CGM detects significantly more hypoglycemic episodes than CBG alone 1, 4, 9
- CBG meters must meet FDA accuracy standards, with several interfering substances able to affect accuracy, including maltose, galactose, and xylose, and professional-use meters in hospitals should meet higher accuracy standards than home-use meters 1, 2, 6, 9
- Proper technique for sample collection and quality control use is essential, and patients must understand when to test and how to use results for insulin dosing decisions 1, 4, 6